All viruses require strategies to inhibit or evade the immunity pathways of cells they 14 infect. The viruses that infect bacteria, bacteriophages (phages), must avoid nucleic-acid 15 targeting immune pathways such as CRISPR-Cas and restriction endonucleases to 16 replicate efficiently 1 . Here, we show that a jumbo phage infecting Pseudomonas 17 aeruginosa, phage ΦKZ, is resistant to many immune systems in vivo, including CRISPR-18 Cas3 (Type I-C), Cas9 (Type II-A), Cas12 (Cpf1, Type V-A), and Type I restriction-19 modification (R-M) systems. We propose that ΦKZ utilizes a nucleus-like shell to protect 20 its DNA from attack. Supporting this, we demonstrate that Cas9 is able to cleave ΦKZ 21 DNA in vitro, but not in vivo and that Cas9 is physically occluded from the shell 22 assembled by the phage during infection. Moreover, we demonstrate that the Achilles 23 heel for this phage is the mRNA, as translation occurs outside of the shell, rendering the 24 phage sensitive to the RNA targeting CRISPR-Cas enzyme, Cas13a (C2c2, Type VI-A).
these phages by the Type I-C system demonstrated functional CRISPR immunity and that these PAK, and then plated on strain PAO1, its titer was reduced by ~3 orders of magnitude ( Fig. 2c ), an effect that was ameliorated in a PAO1 strain lacking the Type I R-M system (∆hsdR).
indeed excluded from the shell during phage infection (Fig. 4a ). DAPI staining reveals the phage studies 28, 29 suggest that the default localization for large host-encoded proteins is to be 121 excluded from the shell.
123
While ΦKZ DNA is protected from CRISPR-Cas and restriction endonucleases, the mRNA is not 124 afforded this same luxury, as it leaves the confines of the shell to be translated in the cytoplasm.
well-suited to target the mRNA of DNA phages when the DNA is inaccessible (i.e. due to base the replication of DNA phages remain to be elucidated as only 3/11 LseCas13a crRNAs tested Here, we searched for CRISPR-Cas resistant phages by designing crRNAs against them and resistant to the Type I-C CRISPR system, and subsequently to Type II-A and Type V-A single 153 effector nucleases Cas9 and Cas12. ΦKZ is also recalcitrant to the Type I restriction-154 modification system of P. aeruginosa. Despite this apparent resistance in vivo, ΦKZ genomic 155 DNA is sensitive to restriction enzymes and Cas9 cleavage in vitro. We propose that the 156 assembly of a proteinaceous compartment to house the replicating phage DNA creates a 157 physical protective barrier resulting in the resistance of phage ΦKZ to DNA-cleaving enzymes 158 ( Fig. 4d ). Although this shell-like structure has only been documented among the jumbo phages 159 of Pseudomonas 28,29 , we consider that physical occlusion of phage genomic DNA through this 160 and other mechanisms may comprise a novel route to immune system evasion in bacteria.
162
The pan-resistance of ΦKZ to DNA-targeting enzymes provides an explanation for the elaborate 163 and impressive shell structure, and suggests that the phage DNA may never be exposed to the 164 cytoplasm. Other hypotheses to describe the shell's existence remain to be addressed,
165
including protection from phage-derived nucleases that degrade the bacterial genome or as a 166 mechanism to spatially restrict the large phage genome during replication and packaging. targeting immune pathways. We expect that simple CRISPR-based screens, such as the one 169 conducted here, may reveal many other fascinating mechanisms that phages have evolved to 170 ensure their replicative success when faced with immune systems to overcome. and an NIH Office of the Director Early Independence Award (DP5-OD021344). This work was also supported by HHMI (DAA) and NIH grants R35GM118099 (DAA), and GM104556 (DAA). Tables: Table 1 : ΦKZ and ΦKZ-like phages have no natural spacers matching their genomes from 251 a natural collection of >4000 P. aeruginosa spacers.
252
The total number of Type I CRISPR spacers with a perfect match to the indicated P. aeruginosa 
292
Phage growth and DNA extraction
293
Phage growth was conducted in LB at 37 °C with PAO1 as a host. Growth curves were 294 conducted in a Biotek Synergy plate reader at 37 °C with orbital shaking set to maximum speed.
295
Phage stocks were diluted and stored in SM buffer 33 and used for routine plaquing assays. For plates. Plates were incubated at 37 °C overnight and were imaged on the following day.
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Restriction-Modification Assay
371
The PAO1 hsdR gene (PA2732) was knocked out using CRISPR-Cas9 and a targeted sgRNA. 
